RENAL FAILURE IS REVERSIBLE AFTER THERAPY WITH BORTEZOMIB IN PATIENTS WITH MULTIPLE MYELOMA

被引：0
|
作者：
Goranova-Marinova, V. [1 ]
Nedeva, A. [2 ]
Nikolov, I. [2 ]
Georgiev, P. [1 ]
Hristova, I. [1 ]
Gigov, I. [2 ]
Raynov, J. [2 ]
Goranov, S. [1 ]
机构：
[1] Univ Hosp Sv Georgi, Clin Hematol, Plovdiv, Bulgaria
[2] Mil Med Acad, Dept Hematol & Oncol, Sofia, Bulgaria
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1508
引用
收藏
页码：602 / 603
页数：2
相关论文
共 50 条
  • [31] The Effect of Bortezomib on Renal Dysfunction in African American Patients with Multiple Myeloma
    Brar, Gagandeep
    Chintala, Parimal
    Catlett, Joseph Patrick
    Shenoy, Aarthi
    BLOOD, 2017, 130
  • [32] Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma
    Sivaraj, Dharshan
    Green, Michael M.
    Li, Zhiguo
    Sung, Anthony D.
    Sarantopoulos, Stefanie
    Kang, Yubin
    Long, Gwynn D.
    Horwitz, Mitchell E.
    Lopez, Richard D.
    Sullivan, Keith M.
    Rizzieri, David A.
    Chao, Nelson J.
    Gasparetto, Cristina
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) : 262 - 268
  • [33] Bortezomib as salvage therapy in patients with relapse of multiple myeloma after allogeneic haernatopoietic cell transplantation
    Hegenbart, U
    Schonland, S
    Munder, M
    Perz, J
    Egerer, G
    Goldschmidt, H
    Ho, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S388 - S388
  • [34] Dorsal Column Degeneration after Bortezomib Therapy in a Patient with Multiple Myeloma
    Joh, Tatsuro
    Sigematu, Kazuto
    Yasui, Jun-Ichi
    Takasaki, Yumi
    Tawara, Masayuki
    Takahara, Osamu
    Tomonaga, Masao
    CASE REPORTS IN ONCOLOGY, 2009, 2 (03): : 184 - 188
  • [35] Reversible acute renal failure following initiation of thalidomide therapy in a patient with relapsed multiple myeloma.
    Womeldorph, JL
    Myhand, RC
    Monahan, BP
    BLOOD, 2001, 98 (11) : 313B - 313B
  • [36] Pooled analysis of the reports of pomalidomide after failure of lenalidomide and (or) bortezomib for multiple myeloma
    Sheng, Zhixin
    Liu, Guangyu
    HEMATOLOGICAL ONCOLOGY, 2016, 34 (02) : 102 - 107
  • [37] REVERSIBILITY OF RENAL FAILURE IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS: A SINGLE CENTRE EXPERIENCE
    Stefanikova, Z.
    Roziakova, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 593 - 593
  • [38] IMPACT OF BORTEZOMIB IN THE SURVIVAL OF PATIENTS WITH REFRACTORY OR RELAPSED MULTIPLE MYELOMA WITH RENAL FAILURE. EXPERIENCE OF A SINGLE CENTRE
    Parrilla Agustin, Carreno
    Belen, Hernandez Ruiz M.
    Primo Carmen, Calle
    Eliana, Olazo
    Elisa, Pereira
    Luis, Piccone
    Alberto, Martinez-Calero
    Javier, Nieto
    Isabel, Ferreras
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 424 - 424
  • [39] Hematology: Synergistic effects of bortezomib and melphalan therapy in patients with multiple myeloma
    Higgs R.
    Nature Reviews Clinical Oncology, 2010, 7 (3) : 124 - 124
  • [40] Combination Therapy Based on Bortezomib for Newly Diagnosed Multiple Myeloma Patients
    He, Jingsong
    Yang, Li
    Jin, Dian
    Lin, Xuanru
    Yang, Qianqian
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Zhang, Jie
    Lin, Maofang
    Huang, He
    Cai, Zhen
    BLOOD, 2012, 120 (21)
12345